ArticleFrontiers in public health2025
Development of real-time PCR methods for quality control detection of pathogenic bacteria in cosmetic preparations.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evaluation of gene markers invA, phsB, and tviA for detection of Salmonella Typhi by SYBR GreenMolecular biology reports · 2026Article
- Molecular identification ofOpen veterinary journal · 2026Article
- A manually driven centrifugal microfluidic LAMP platform for rapid visual detection of waterborne pathogens in aquatic sports.Scientific reports · 2025Article
- Fate and Removal of Antibiotics and Antibiotic Resistance Genes in a Rural Wastewater Treatment Plant: A Microbial Perspective of Nature-Based Versus Advanced Technologies.Microorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The preservation of microbial safety in cosmetic products is essential for consumer health and requires rapid and accurate detection strategies… Traditional detection methods, such as quantitative and qualitative tests, are effective but often time-consuming and labor-intensive. Moreover, plate count methods fail to detect viable but non-cultivable cells, which remain alive but cannot grow under standard laboratory conditions. To address these limitations, molecular techniques like PCR, particularly real-time PCR (rt-PCR), multiplex rt-PCR, and viability PCR assays, as well as flow cytometry, have enhanced microbiological analysis by improving detection sensitivity, accuracy, and enabling rapid pathogen identification. ISO standards offer guidelines for reliable and consistent microbial detection methods, to guarantee the effectiveness of traditional and molecular techniques in food and cosmetic safety testing. Methods: This study evaluates real-time PCR (rt-PCR) as an alternative to the traditional plate-based method for the detection of Results and discussion: rt-PCR consistently demonstrated superior sensitivity and reliability, particularly in detecting pathogens at low inoculum levels and within complex matrices. For all pathogens, rt-PCR achieved a 100% detection rate across all replicates, reaching the same or superior results than the classical plate method. rt-PCR's ability to directly target DNA overcomes issues related to colony morphology and microbial competition. The study highlights the necessity of standardized rt-PCR protocols aligned with international ISO guidelines to enhance its applicability in routine quality control programs. In conclusion, rt-PCR represents a significant advancement in microbial safety for food and cosmetics, offering a rapid, sensitive, and reliable alternative to conventional methods. By integrating enrichment strategies, rt-PCR ensures higher accuracy in pathogen detection, reinforcing product safety and regulatory compliance in the cosmetics industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.